{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:58:29Z","timestamp":1772600309480,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00467-025-06862-7","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:24:10Z","timestamp":1750818250000},"page":"3423-3436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Parental perspectives on the effectiveness and safety of rituximab in treating pediatric nephrotic syndrome: a nationwide multi-center survey study"],"prefix":"10.1007","volume":"40","author":[{"given":"Ning","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4452-3674","authenticated-orcid":false,"given":"Gaofu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"6862_CR1","doi-asserted-by":"publisher","first-page":"l1800","DOI":"10.1136\/bmj.l1800","volume":"365","author":"NJA Webb","year":"2019","unstructured":"Webb NJA, Lambe T, Shah V et al (2019) Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ 365:l1800","journal-title":"BMJ"},{"key":"6862_CR2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2215\/CJN.00380116","volume":"11","author":"THM Banh","year":"2016","unstructured":"Banh THM, Hussain-Shamsy N, Patel V et al (2016) Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome. Clin J Am Soc Nephrol 11:1760\u20131768","journal-title":"Clin J Am Soc Nephrol"},{"key":"6862_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","volume":"97","author":"EY Chan","year":"2020","unstructured":"Chan EY, Kim JS, Wei A et al (2020) Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney Int 97:393\u2013401","journal-title":"Kidney Int"},{"key":"6862_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K et al (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281","journal-title":"Lancet"},{"key":"6862_CR5","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC et al (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"6862_CR6","doi-asserted-by":"crossref","unstructured":"Rehan ST, Mohamed MF, Shabih H et al (2024) Meta-analysis on the efficacy and safety of rituximab versus tacrolimus for nephrotic syndrome in the paediatric age group. Clin Kidney J 17:sfad263","DOI":"10.1093\/ckj\/sfad263"},{"key":"6862_CR7","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2014080799","volume":"26","author":"P Ravani","year":"2015","unstructured":"Ravani P, Magnasco A, Edefonti A et al (2015) Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. J Am Soc Nephrol 26:2259\u20132266","journal-title":"J Am Soc Nephrol"},{"key":"6862_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ndt\/gfae228","volume":"40","author":"D Hirano","year":"2025","unstructured":"Hirano D, Fujimaru T, Sako M et al (2025) Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome. Nephrol Dial Transplant 40:967\u2013977","journal-title":"Nephrol Dial Transplant"},{"key":"6862_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00467-021-05304-4","volume":"37","author":"Y Inoki","year":"2022","unstructured":"Inoki Y, Kamei K, Nishi K et al (2022) Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome. Pediatr Nephrol 37:1057\u20131066","journal-title":"Pediatr Nephrol"},{"key":"6862_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12519-014-0453-5","volume":"10","author":"L Sun","year":"2014","unstructured":"Sun L, Jia Y, Zhuang H et al (2014) Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai. World J Pediatr 10:59\u201363","journal-title":"World J Pediatr"},{"key":"6862_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00467-017-3789-y","volume":"33","author":"F Iorember","year":"2018","unstructured":"Iorember F, Aviles D, Williams R et al (2018) Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome. Pediatr Nephrol 33:261\u2013267","journal-title":"Pediatr Nephrol"},{"key":"6862_CR12","doi-asserted-by":"publisher","first-page":"619548","DOI":"10.3389\/fped.2020.619548","volume":"8","author":"CL Tran","year":"2020","unstructured":"Tran CL, Williams EC, Beers K et al (2020) Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge. Front Pediatr 8:619548","journal-title":"Front Pediatr"},{"key":"6862_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Mahapatra TK, Mondal S et al (2018) Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial. JAMA Pediatr 172:757\u2013764","journal-title":"JAMA Pediatr"},{"key":"6862_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12519-022-00622-5","volume":"19","author":"HM Huang","year":"2023","unstructured":"Huang HM, Hsiao CC, Lu MY et al (2023) Depression in children with nephrotic syndrome related to parents\u2019 stress, quality of life, and depression. World J Pediatr 19:194\u2013199","journal-title":"World J Pediatr"},{"key":"6862_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000535010","volume":"55","author":"L Lan","year":"2024","unstructured":"Lan L, Liu Y, Sun S et al (2024) Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study. Am J Nephrol 55:25\u201336","journal-title":"Am J Nephrol"},{"key":"6862_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fped.2019.00178","volume":"7","author":"M Kallash","year":"2019","unstructured":"Kallash M, Smoyer WE, Mahan JD (2019) Rituximab Use in the Management of Childhood Nephrotic Syndrome. Front Pediatr 7:178","journal-title":"Front Pediatr"},{"key":"6862_CR17","doi-asserted-by":"publisher","first-page":"e064216","DOI":"10.1136\/bmjopen-2022-064216","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Wang J, Guo L et al (2022) Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome. BMJ Open 12:e064216","journal-title":"BMJ Open"},{"key":"6862_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrneph.2015.117","volume":"11","author":"JK Deegens","year":"2015","unstructured":"Deegens JK, Wetzels JF (2015) Therapy: Maintenance of steroid-free remission in nephrotic syndrome. Nat Rev Nephrol 11:569\u2013570","journal-title":"Nat Rev Nephrol"},{"key":"6862_CR19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-020-04570-y","volume":"35","author":"JA Kari","year":"2020","unstructured":"Kari JA, Barahmeh A, Alhasan KA et al (2020) Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol 35:1445\u20131453","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06862-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:11:14Z","timestamp":1759234274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06862-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6862"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06862-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6265885\/v1","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted according to the Declaration of Helsinki, and was approved by the Medical Ethics Committee of the Children\u2019s Hospital of Chongqing Medical University (Approval No. (49), 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All parents gave their consent and voluntarily participated in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}